ALKBH5 and breast cancer: Additionally, ALKBH5 and ZNF217 were found to regulate a breast cancer stem cell (BCSC) phenotype in hypoxia, resulting in decreased m6A methylation of NANOG and KLF4 and increased expression of these pluripotency factors [33,34].